Literature DB >> 29120580

Serum Level of IL17a among Cirrhotic Hepatitis C Virus Infected Patients with Incidence of Diabetes Mellitus.

Helal F Hetta1, Azza Elkady2, Khairy H Morsy3, Ismael S Mohamed1, Maggie A Ibrahim1.   

Abstract

IL17a is the key inflammatory cytokine of TH17 and contributes to the pathogenesis of diabetes mellitus which is a common endocrine disorder associated with HCV infection. Herein, 183 cirrhotic HCV infected patients were screened for ANA by ELISA and positive cases (n=40) were screened for ICA by Immunofluorescence and IL17a serum levels were measured by ELISA and compared to a control group (n=24). Out of 40 cirrhotic HCV, ANA (+) infected patients, 16 patients (40 %) were type 2 diabetic and 13 (32.5%) were non-diabetic. On the other hand, 17 positive ICA (42.5%) and 23 negative ICA (57.5%) patients were reported. IL17a serum level was significantly elevated in cirrhotic HCV infected patients who were positive for ICA than negative ICA (P < 0.0001) and was significantly higher in type 2 diabetic than both non-diabetic patients (P=0.04) and controls (P=0.0005). In conclusion, IL17 serum levels were elevated in diabetic HCV infected patients. Copyright© by the Egyptian Association of Immunologists.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29120580

Source DB:  PubMed          Journal:  Egypt J Immunol


  7 in total

1.  Metoclopramide nanoparticles modulate immune response in a diabetic rat model: association with regulatory T cells and proinflammatory cytokines.

Authors:  Noura H Abd Ellah; Esraa A Ahmed; Rasha B Abd-Ellatief; Marwa F Ali; Asmaa M Zahran; Helal F Hetta
Journal:  Int J Nanomedicine       Date:  2019-04-03

2.  Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C.

Authors:  Hala Rady Ahmed; Nancy G F M Waly; Rehab Mahmoud Abd El-Baky; Ramadan Yahia; Helal F Hetta; Amr M Elsayed; Reham Ali Ibrahem
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

Review 3.  Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.

Authors:  Sandra Rayego-Mateos; José Luis Morgado-Pascual; Lucas Opazo-Ríos; Melania Guerrero-Hue; Cristina García-Caballero; Cristina Vázquez-Carballo; Sebastián Mas; Ana Belén Sanz; Carmen Herencia; Sergio Mezzano; Carmen Gómez-Guerrero; Juan Antonio Moreno; Jesús Egido
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

4.  Does a diabetic retinopathy educational program raise awareness among elderly diabetic patients?

Authors:  Fatma R Khalaf; Heba M Fahmy; Ahmed K Ibrahim; Ghada A Mohamed; Manal El Sayed Ez Eldeen; Azza Elkady; Helal F Hetta
Journal:  Diabetes Metab Syndr Obes       Date:  2019-09-20       Impact factor: 3.168

Review 5.  Cytotoxic Chemotherapy as an Alternative for Systemic Treatment of Advanced Hepatocellular Carcinoma in Developing Countries.

Authors:  Khaled Abouelezz; Dipen Khanapara; Gaber El-Saber Batiha; Esraa A Ahmed; Helal F Hetta
Journal:  Cancer Manag Res       Date:  2020-11-27       Impact factor: 3.989

6.  Impact of Ginkgo biloba extract and magnetized water on the survival rate and functional capabilities of pancreatic β-cells in type 2 diabetic rat model.

Authors:  Ahmed Saleh; Mamdouh M Anwar; Ahmed E Zayed; Manal El Sayed Ezz Eldeen; Gamal Afifi; Hassien M Alnashiri; Asmaa Ms Gomaa; Mahmoud Abd-Elkareem; Alaa Sayed Abou-Elhamd; Emad S Shaheen; Ghada A Mohamed; Helal F Hetta; Ahmed M Kotb
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-07       Impact factor: 3.168

Review 7.  Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?

Authors:  Carolina Lavoz; Sandra Rayego-Mateos; Macarena Orejudo; Lucas Opazo-Ríos; Vanessa Marchant; Laura Marquez-Exposito; Antonio Tejera-Muñoz; Juan F Navarro-González; Alejandra Droguett; Alberto Ortiz; Jesús Egido; Sergio Mezzano; Raúl R Rodrigues-Diez; Marta Ruiz-Ortega
Journal:  J Clin Med       Date:  2020-01-19       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.